CLINICAL STUDY: INTERVENTIONAL CARDIOLOGY
The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation
Andrew E. Ajani, MBBS*,
Ron Waksman, MD, FACC*,*,
Dong-Hun Cha, MD*,
Luis Gruberg, MD*,
Lowell F. Satler, MD, FACC*,
Augusto D. Pichard, MD, FACC* and
Kenneth M. Kent, MD, FACC*
* Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C., USA
Manuscript received May 24, 2001;
revised manuscript received January 7, 2002,
accepted January 18, 2002.
* Reprint requests and correspondence: Dr. Ron Waksman, 110 Irving Street, NW, Suite 4B-1, Washington, DC 20010, USA ron.waksman{at}medstar.net
OBJECTIVES: The study assessed the influence of lesion length and reference vessel diameter (RVD) on recurrent restenosis after gamma intracoronary radiation therapy (ICRT) for in-stent restenosis (IRS).
BACKGROUND: Intracoronary radiation therapy reduces angiographic and clinical restenosis in patients with ISR. The impact of ICRT on challenging subgroups, such as long lesions and small vessels, has not been established.
METHODS: Six-month quantitative coronary angiography and clinical follow-up were conducted to evaluate the influence of lesion length and RVD in patients with ISR treated with ICRT who were enrolled in gamma radiation trials. Angiographic binary restenosis (>50% diameter stenosis) and clinical events were assessed in 311 patients treated with gamma ICRT and 105 patients who received placebo.
RESULTS: Baseline demographic, angiographic and procedural details were similar in the two treatment groups. The ICRT group had reduced binary restenosis in vessels of all sizes (30% vs. 66%, p < 0.001), with the most benefit seen in small vessels. A trend toward reduced restenosis with ICRT was found across all lesion lengths. At six months, major adverse cardiac events (MACE) were reduced in the ICRT group compared to placebo (34% vs. 71%, p < 0.0001), driven by reduced target vessel revascularization (27% vs. 71%, p < 0.0001). The independent predictors of angiographic restenosis include ICRT (OR [odds ratio] 0.16; CI [confidence interval] 0.10 to 0.28, p < 0.001), lesion length (OR 1.03; CI 1.01 to 1.05, p = 0.004) and RVD (OR 0.40; CI 0.23 to 0.67, p < 0.001).
CONCLUSIONS: Intracoronary radiation therapy, compared to placebo, results in a significant reduction of angiographic restenosis across all vessel sizes, with a trend toward reduction of angiographic restenosis across all lesion lengths; this effect is seen predominantly in small vessels and diffuse lesions.
|
Abbreviations and Acronyms
| | CI | | confidence interval | | ICRT | | intracoronary radiation therapy | | ISR | | in-stent restenosis | | IVUS | | intravascular ultrasound | | LTO | | late total occlusion | | LVEF | | left ventricular ejection fraction | | MACE | | major adverse cardiac events | | MI | | myocardial infarction | | MLD | | minimal luminal diameter | | OR | | odds ratio | | PTCA | | percutaneous transluminal coronary angioplasty | | QCA | | quantitative coronary angiography | | RVD | | reference vessel diameter | | SCRIPPS | | Scripps Coronary Radiation to Inhibit Proliferation Post Stenting | | TLR | | target lesion revascularization | | TVR | | target vessel revascularization | | WRIST | | Washington Radiation for In-Stent restenosis Trial |
|
This article has been cited by other articles:

|
 |

|
 |
 
L. Ge, I. Iakovou, J. Cosgrave, A. Chieffo, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, G. Melzi, G. M. Sangiorgi, et al.
Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions
Eur. Heart J.,
June 1, 2005;
26(11):
1056 - 1062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Waksman
Reply
J. Am. Coll. Cardiol.,
July 16, 2003;
42(2):
396 - 396.
[Full Text]
[PDF]
|
 |
|
|